You are seeing this message because your Web browser does not support basic Web standards. Find out more about why this message is appearing and what you can do to make your experience on this site better.


ABOUT JAMA
Advanced Search

Welcome   | My Account | E-mail Alerts | Access Rights | Sign In


  Vol. 301 No. 10, March 11, 2009 TABLE OF CONTENTS
  JAMA
  •  Online Features
  Letters
 This Article
 •Full text
 •PDF
 •Send to a friend
 • Save in My Folder
 •Save to citation manager
 •Permissions
 Citing Articles
 •Contact me when this article is cited
 Related Content
 •Related letters
 •Similar articles in JAMA
 Topic Collections
 •Pacemakers/ Defibrillators
 •Cardiovascular System
 •Arrhythmias
 •Drug Therapy
 •Adverse Effects
 •Drug Therapy, Other
 •Cardiovascular Intervention
 •Alert me on articles by topic
 Social Bookmarking
  Add to CiteULike Add to Connotea Add to Del.icio.us Add to Digg Add to Reddit Add to Technorati Add to Twitter What's this?

Treatment With Amiodarone to Prevent Atrial Fibrillation—Reply

Since this article does not have an abstract, we have provided the first 150 words of the full text and any section headings.

In Reply: As noted by Dr Santangeli and colleagues, the episodic amiodarone treatment group had significantly larger left atria compared with the continuous amiodarone treatment group. On the other hand, a nonsignificantly greater number of patients in the episodic amiodarone treatment group were using ACE inhibitors, with comparable blood pressure measurements at baseline and history of hypertension. Along with smaller atrial size, the use of ACE inhibitors and angiotensin II receptor blockers are predictors for sinus rhythm maintenance in union with amiodarone therapy.1 Statins may also play a role in prevention of atrial fibrillation due to pleiotropic effects such as attenuation of inflammation and antioxidant effects.2 We are currently conducting a subanalysis to find predictors for the maintenance of sinus rhythm in both treatment groups.

Bleeding complications occurred more often in the episodic amiodarone treatment group. We conducted our study in the Netherlands, and the Dutch guidelines state that for . . . [Full Text of this Article]

Sheba Ahmed, MD
Department of Cardiology
University Medical Center Groningen
University of Groningen
Groningen, the Netherlands

Harry J. G. M. Crijns, MD, PhD
Department of Cardiology
Maastricht University Medical Center
Maastricht, the Netherlands

Isabelle C. Van Gelder, MD, PhD
i.c.van.gelder@thorax.umcg.nl
Department of Cardiology
University Medical Center Groningen
Groningen



Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Reddit Reddit   Add to Technorati Technorati   Add to Twitter Twitter     What's this?

RELATED LETTERS

Treatment With Amiodarone to Prevent Atrial Fibrillation
Pasquale Santangeli, Antonio Dello Russo, and Fulvio Bellocci
JAMA. 2009;301(10):1019.
EXTRACT | FULL TEXT  

Treatment With Amiodarone to Prevent Atrial Fibrillation
Madhavi Bollu, Ravi K. Bobba, and Edward L. Arsura
JAMA. 2009;301(10):1019-1020.
EXTRACT | FULL TEXT  






HOME | CURRENT ISSUE | PAST ISSUES | TOPIC COLLECTIONS | CME | SUBMIT | SUBSCRIBE | HELP
CONDITIONS OF USE | PRIVACY POLICY | CONTACT US | SITE MAP
 
© 2009 American Medical Association. All Rights Reserved.